Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19
Complement, a critical defence against pathogens, has been implicated as a driver of pathology in COVID-19. Complement activation products are detected in plasma and tissues and complement blockade considered for therapy. To delineate roles of complement in immunopathogenesis, we undertook the large...
Prif Awduron: | Siggins, M, Davies, K, Fellows, R, Thwaites, R, Baillie, K, Semple, M, Openshaw, P, Zelek, W, Harris, CL, Morgan, BP, Dunning, W |
---|---|
Awduron Eraill: | The ISARIC4C Investigators |
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Wiley
2022
|
Eitemau Tebyg
-
Dysregulation of complement system in HELLP syndrome
gan: Shi Chen, et al.
Cyhoeddwyd: (2021-10-01) -
Measuring Total Classical Pathway and Activities of Individual Components of the Mouse Complement Pathway
gan: Wioleta Zelek
Cyhoeddwyd: (2021-10-01) -
Kinetic analysis of the interaction between the complement regulators CD46 and CD55 and components of the alternative pathway of complement
gan: Harris, C, et al.
Cyhoeddwyd: (2004) -
Complement dysregulation is associated with severe COVID-19 illness
gan: Jia Yu, et al.
Cyhoeddwyd: (2021-07-01) -
Seasonal and pandemic influenza: 100 years of progress, still much to learn
gan: Dunning, WJ, et al.
Cyhoeddwyd: (2020)